DK1235536T3 - Medicinsk anordning, der omfatter en syntetisk overflade med nukleinsyre til in vivoinduktion af en endothelisering af anordningen - Google Patents

Medicinsk anordning, der omfatter en syntetisk overflade med nukleinsyre til in vivoinduktion af en endothelisering af anordningen

Info

Publication number
DK1235536T3
DK1235536T3 DK00986137T DK00986137T DK1235536T3 DK 1235536 T3 DK1235536 T3 DK 1235536T3 DK 00986137 T DK00986137 T DK 00986137T DK 00986137 T DK00986137 T DK 00986137T DK 1235536 T3 DK1235536 T3 DK 1235536T3
Authority
DK
Denmark
Prior art keywords
nucleic acid
synthetic surface
present
medical device
endothelialization
Prior art date
Application number
DK00986137T
Other languages
Danish (da)
English (en)
Inventor
Mika Lahtinen
Original Assignee
Fit Biotech Oy Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9904454A external-priority patent/SE9904454D0/xx
Priority claimed from SE9904747A external-priority patent/SE9904747D0/xx
Application filed by Fit Biotech Oy Plc filed Critical Fit Biotech Oy Plc
Application granted granted Critical
Publication of DK1235536T3 publication Critical patent/DK1235536T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/507—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials for artificial blood vessels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/005—Ingredients of undetermined constitution or reaction products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/258—Genetic materials, DNA, RNA, genes, vectors, e.g. plasmids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Vascular Medicine (AREA)
  • Surgery (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Surgical Instruments (AREA)
  • External Artificial Organs (AREA)
  • Eye Examination Apparatus (AREA)
DK00986137T 1999-12-07 2000-12-07 Medicinsk anordning, der omfatter en syntetisk overflade med nukleinsyre til in vivoinduktion af en endothelisering af anordningen DK1235536T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SE9904454A SE9904454D0 (sv) 1999-12-07 1999-12-07 Medical implant
SE9904747A SE9904747D0 (sv) 1999-12-07 1999-12-23 Medical Implant
SE0000285A SE0000285D0 (sv) 1999-12-07 2000-01-31 Medical implant
PCT/SE2000/002460 WO2001041674A1 (en) 1999-12-07 2000-12-07 Medical device

Publications (1)

Publication Number Publication Date
DK1235536T3 true DK1235536T3 (da) 2003-10-20

Family

ID=27354498

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00986137T DK1235536T3 (da) 1999-12-07 2000-12-07 Medicinsk anordning, der omfatter en syntetisk overflade med nukleinsyre til in vivoinduktion af en endothelisering af anordningen

Country Status (13)

Country Link
US (1) US20030059463A1 (es)
EP (1) EP1235536B1 (es)
JP (1) JP2003516180A (es)
CN (1) CN1239133C (es)
AT (1) ATE243479T1 (es)
AU (1) AU782237B2 (es)
CA (1) CA2392284C (es)
DE (1) DE60003580T2 (es)
DK (1) DK1235536T3 (es)
ES (1) ES2206342T3 (es)
HK (1) HK1054858A1 (es)
SE (1) SE0000285D0 (es)
WO (1) WO2001041674A1 (es)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030008396A1 (en) * 1999-03-17 2003-01-09 Ku David N. Poly(vinyl alcohol) hydrogel
US6596699B2 (en) 1998-09-22 2003-07-22 Biosurface Engineering Technologies, Inc. Nucleic acid coating compositions and methods
US6368658B1 (en) * 1999-04-19 2002-04-09 Scimed Life Systems, Inc. Coating medical devices using air suspension
US7592017B2 (en) 2000-03-10 2009-09-22 Mast Biosurgery Ag Resorbable thin membranes
US8632583B2 (en) * 2011-05-09 2014-01-21 Palmaz Scientific, Inc. Implantable medical device having enhanced endothelial migration features and methods of making the same
US9089450B2 (en) 2000-11-14 2015-07-28 Cochlear Limited Implantatable component having an accessible lumen and a drug release capsule for introduction into same
AUPR148400A0 (en) 2000-11-14 2000-12-07 Cochlear Limited Apparatus for delivery of pharmaceuticals to the cochlea
ATE393235T1 (de) * 2000-11-27 2008-05-15 Dnavec Research Inc Für fibroblasten-wachstumsfaktor 2 (fgf2) kodierender paramyxovirus-vektor und dessen verwendung
AUPR879201A0 (en) 2001-11-09 2001-12-06 Cochlear Limited Subthreshold stimulation of a cochlea
US20030114923A1 (en) * 2001-11-14 2003-06-19 Swanick Thomas M. Graft and method of making
US8048444B2 (en) * 2002-07-31 2011-11-01 Mast Biosurgery Ag Apparatus and method for preventing adhesions between an implant and surrounding tissues
US7767222B2 (en) * 2002-07-31 2010-08-03 Mast Biosurgery Ag Apparatus and method for preventing adhesions between an implant and surrounding tissues
US7704520B1 (en) * 2002-09-10 2010-04-27 Mast Biosurgery Ag Methods of promoting enhanced healing of tissues after cardiac surgery
WO2004050056A1 (en) * 2002-11-29 2004-06-17 Cochlear Limited Cochlear implant drug delivery device
US7627373B2 (en) * 2002-11-30 2009-12-01 Cardiac Pacemakers, Inc. Method and apparatus for cell and electrical therapy of living tissue
US7044965B1 (en) * 2002-12-13 2006-05-16 Spielberg Theodore E Therapeutic cellular stent
US7371256B2 (en) * 2002-12-16 2008-05-13 Poly-Med, Inc Composite vascular constructs with selectively controlled properties
US20060083767A1 (en) * 2003-02-27 2006-04-20 Kai Deusch Surgical prosthesis having biodegradable and nonbiodegradable regions
US20070015960A1 (en) * 2003-02-28 2007-01-18 Schaerer Mayfield Technologies Gmbh Device for localizing, influencing and guiding of tracking bodies, and method for operating a marking device
US20040230298A1 (en) * 2003-04-25 2004-11-18 Medtronic Vascular, Inc. Drug-polymer coated stent with polysulfone and styrenic block copolymer
EP1653865A2 (en) * 2003-05-23 2006-05-10 Angiotech International Ag Anastomotic connector devices
DE10328816A1 (de) * 2003-06-21 2005-01-05 Biotronik Meß- und Therapiegeräte GmbH & Co. Ingenieurbüro Berlin Implantierbare Stimulationselektrode mit einer Beschichtung zur Erhöhung der Gewebsverträglichkeit
US20100266663A1 (en) * 2003-09-10 2010-10-21 Calhoun Christopher J Tissue-treating implantable compositions
US8435285B2 (en) * 2003-11-25 2013-05-07 Boston Scientific Scimed, Inc. Composite stent with inner and outer stent elements and method of using the same
WO2005077013A2 (en) * 2004-02-06 2005-08-25 Georgia Tech Research Corporation Surface directed cellular attachment
EP1729678A4 (en) * 2004-02-06 2011-08-10 Georgia Tech Res Inst BEARING BIOCOMPATIBLE DEVICE
US7840263B2 (en) * 2004-02-27 2010-11-23 Cardiac Pacemakers, Inc. Method and apparatus for device controlled gene expression
US8293890B2 (en) * 2004-04-30 2012-10-23 Advanced Cardiovascular Systems, Inc. Hyaluronic acid based copolymers
US7764995B2 (en) 2004-06-07 2010-07-27 Cardiac Pacemakers, Inc. Method and apparatus to modulate cellular regeneration post myocardial infarct
US20050278025A1 (en) * 2004-06-10 2005-12-15 Salumedica Llc Meniscus prosthesis
US7534422B2 (en) * 2004-07-09 2009-05-19 Viscofan, S.A. Universal fishing bait based on fibrous collagen and the procedure for its preparation
US7556800B2 (en) * 2004-07-09 2009-07-07 Viscofan, S.A Universal fishing bait based on filaments or strips of fibrous collagen
US7729761B2 (en) * 2004-07-14 2010-06-01 Cardiac Pacemakers, Inc. Method and apparatus for controlled gene or protein delivery
DE602005017708D1 (de) * 2004-07-28 2009-12-31 Cordis Corp Bifurkationsprothese zur Reparatur eines Bauchaortenaneurysmas
US20080091277A1 (en) * 2004-08-13 2008-04-17 Kai Deusch Surgical prosthesis having biodegradable and nonbiodegradable regions
ATE545384T1 (de) * 2004-08-13 2012-03-15 Mast Biosurgery Ag Chirurgische prothese mit biologisch abbaubaren und nichtabbaubaren regionen
WO2006026325A2 (en) * 2004-08-26 2006-03-09 Pathak Chandrashekhar P Implantable tissue compositions and method
US8060219B2 (en) * 2004-12-20 2011-11-15 Cardiac Pacemakers, Inc. Epicardial patch including isolated extracellular matrix with pacing electrodes
US7981065B2 (en) 2004-12-20 2011-07-19 Cardiac Pacemakers, Inc. Lead electrode incorporating extracellular matrix
US20070032722A1 (en) * 2005-05-19 2007-02-08 Biophan Technologies, Inc. Electromagnetic resonant circuit sleeve for implantable medical device
US20080119878A1 (en) * 2005-08-12 2008-05-22 Kai Deusch Surgical prosthesis having biodegradable and nonbiodegradable regions
US7774057B2 (en) 2005-09-06 2010-08-10 Cardiac Pacemakers, Inc. Method and apparatus for device controlled gene expression for cardiac protection
US20070134204A1 (en) * 2005-12-09 2007-06-14 Henrich Cheng Method for treating nerve injury and vector construct for the same
US9629626B2 (en) * 2006-02-02 2017-04-25 Covidien Lp Mechanically tuned buttress material to assist with proper formation of surgical element in diseased tissue
US20070190028A1 (en) * 2006-02-13 2007-08-16 Jihong Qu Method and apparatus for heat or electromagnetic control of gene expression
DE102006053260A1 (de) * 2006-07-20 2008-01-24 Clinical House Europe Gmbh Implantat zur Verankerung von Zahnersatz
US20080171972A1 (en) * 2006-10-06 2008-07-17 Stopek Joshua B Medical device package
US8133215B2 (en) 2007-08-13 2012-03-13 Cochlear Limited Independently-manufactured drug delivery module and corresponding receptacle in an implantable medical device
CN101474456B (zh) * 2009-02-09 2012-02-22 乐普（北京）医疗器械股份有限公司 一种携载基因的医疗器械的制备方法
CN101502696B (zh) * 2009-02-17 2012-07-11 乐普（北京）医疗器械股份有限公司 一种携载基因和/或药物的医疗器械及其制备方法
US8617097B2 (en) 2010-05-24 2013-12-31 Cochlear Limited Drug-delivery accessory for an implantable medical device
US8597948B2 (en) 2011-03-10 2013-12-03 First Principles, Inc. Cloned biological material medical device and method thereof
EP2757964B1 (en) 2011-05-26 2016-05-04 Cartiva, Inc. Tapered joint implant and related tools
US10550187B2 (en) * 2014-10-24 2020-02-04 Incept, Llc Extra luminal scaffold
WO2016161026A1 (en) 2015-03-31 2016-10-06 Cartiva, Inc. Carpometacarpal (cmc) implants and methods
EP3277219B1 (en) 2015-03-31 2020-07-29 Cartiva, Inc. Hydrogel implants with porous materials
CA2981074C (en) 2015-04-14 2023-03-28 Cartiva, Inc. Tooling for creating tapered opening in tissue and related methods
JP7414529B2 (ja) 2017-06-07 2024-01-16 シファメド・ホールディングス・エルエルシー 血管内流体移動デバイス、システム、および使用方法
WO2019094963A1 (en) 2017-11-13 2019-05-16 Shifamed Holdings, Llc Intravascular fluid movement devices, systems, and methods of use
US10722631B2 (en) 2018-02-01 2020-07-28 Shifamed Holdings, Llc Intravascular blood pumps and methods of use and manufacture
CN108938143A (zh) * 2018-08-15 2018-12-07 湖南工业大学 一种三层结构小口径仿生血管及其制备方法
WO2021011473A1 (en) 2019-07-12 2021-01-21 Shifamed Holdings, Llc Intravascular blood pumps and methods of manufacture and use
US11654275B2 (en) 2019-07-22 2023-05-23 Shifamed Holdings, Llc Intravascular blood pumps with struts and methods of use and manufacture
US11724089B2 (en) 2019-09-25 2023-08-15 Shifamed Holdings, Llc Intravascular blood pump systems and methods of use and control thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7208179B1 (en) * 1990-11-27 2007-04-24 The American National Red Cross Methods for treating disease and forming a supplemented fibrin matrix
US5782789A (en) * 1994-10-19 1998-07-21 Atrium Medical Corporation Macrochannel phosthetic/delivery patch
EP1018977B1 (en) * 1995-05-26 2004-12-08 SurModics, Inc. Method and implantable article for promoting endothelialization
HU223957B1 (hu) * 1996-11-01 2005-03-29 Eurogene Limited A VEGF fehérje vagy egy ezt kódoló nukleinsav terápiás alkalmazása és implantátum, különösen érbelhártya hiperplázia esetében
US5972027A (en) * 1997-09-30 1999-10-26 Scimed Life Systems, Inc Porous stent drug delivery system
GB9809082D0 (en) * 1998-04-28 1998-06-24 Eurogene Limited Delivery device
US6497729B1 (en) * 1998-11-20 2002-12-24 The University Of Connecticut Implant coating for control of tissue/implant interactions
US6398808B1 (en) * 1999-06-15 2002-06-04 Scimed Life Systems, Inc. Localized delivery of genetic information from biostable materials

Also Published As

Publication number Publication date
EP1235536B1 (en) 2003-06-25
AU782237B2 (en) 2005-07-14
ATE243479T1 (de) 2003-07-15
JP2003516180A (ja) 2003-05-13
CN1239133C (zh) 2006-02-01
SE0000285D0 (sv) 2000-01-31
CA2392284A1 (en) 2001-06-14
CN1407873A (zh) 2003-04-02
CA2392284C (en) 2009-08-18
WO2001041674A1 (en) 2001-06-14
US20030059463A1 (en) 2003-03-27
ES2206342T3 (es) 2004-05-16
DE60003580T2 (de) 2004-05-27
AU2242901A (en) 2001-06-18
DE60003580D1 (de) 2003-07-31
EP1235536A1 (en) 2002-09-04
HK1054858A1 (en) 2003-12-19

Similar Documents

Publication Publication Date Title
DK1235536T3 (da) Medicinsk anordning, der omfatter en syntetisk overflade med nukleinsyre til in vivoinduktion af en endothelisering af anordningen
ATE214903T1 (de) Verwendung von perfluorkohlenwasserstoffen zur herstellung von potenzierungsmitteln für die ultraschallvermittelte hyperthermiebehandlung von biologischen geweben
WO2002060955A3 (en) Modified antibodies and methods of use
ATE172625T1 (de) Verfahren zur lokalen therapeutischen erhitzung von biologischen geweben und flüssigkeiten mittels gasgefüllter liposome
AU2003285876A1 (en) Treatment of spinal metastases
EP2343047A3 (en) Optically-active nanoparticles for use in therapeutic and diagnostic methods
WO2005001080A3 (en) Postpartum-derived cells for use in treatment of disease of the heart and circulatory system
WO2002064157A3 (en) Localized myocardial injection method for treating ischemic myocardium
WO2003032815A3 (en) Medical device for delivering patches
ATE370749T1 (de) Zusammensetzungen von nucleinsäure und viskosität-erhöhendem polymer pvp, zur verwendung in gentherapie
WO2004110360A3 (en) Proteoglycan degrading mutants for treatment of cns
PT1267897E (pt) Tratamento da insufuciencia cardiaca congestiva com sangue autologo previamente tratado
WO2002045431A3 (en) Genetically engineered herpes virus for the treatment of cardiovascular disease
WO1999048536A3 (en) Delivery of long lasting therapeutic agents by forming covalent attachments in vivo
DE59600683D1 (de) Verwendung von Trospiumchlorid zur Herstellung eines Arzneimittels zur Behandlung von Blasenkrankheiten
Chen et al. Biofabricating hollow microneedle array with controllable microstructure for cell transplantation
WO2003039591A3 (de) Allogene vakzine enthaltend eine ein costimulatorisches polypeptid exprimierende tumorzelle
ATE267843T1 (de) Verfahren zur herstellung von selbstvernetzten hyaluronsäuren und deren derivaten mittels superkritischer anti-lösungsmittel
CN2553789Y (zh) 多用磁性皮极针
WO2001022976A3 (en) Combination of a statin and ex-vivo treated blood for treating artheroclerosis
UA40019A (uk) Вентрикулярний резервуар з титановою пластиною
ATE356588T1 (de) Verfahren zur herstellung eines katheters mit verbesserten elektrischen eigenschaften
UA28342A (uk) Спосіб одержання біологічно активної речовини для лікування серцевих захворювань
UA36452A (uk) Спосіб декомпресивної трепанації черепа
UA31317A (uk) Спосіб формування додаткового кровопостачання при дистрофії яєчок